mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.08 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.078 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.08 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.09 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.09 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |